Head-to-head dispatch
Kin Meds vs NuvaHealth
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…
Marked down on: Legal entity name and state of incorporation not publicly disclosed
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Desk Score
NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.
Marked down on: Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
NuvaHealth takes this head-to-head with the higher Desk Score, 69/100 (C) against 68/100 (C) for Kin Meds. Kin Meds still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Kin Meds
68/100
C
NuvaHealth
69/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Kin Meds | NuvaHealth |
|---|---|---|
| Semaglutide | $149/mo (brand Wegovy) | $139/mo (first-month rate, compounded) |
| Tirzepatide | $149/mo (brand Zepbound) | $229/mo (first-month rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Readers who want compounded and brand-name GLP-1 plus a longevity stack on one platform. | Readers who want low first-month compounded GLP-1 pricing with 24/7 support. |
| Desk Score | 68/100C | 69/100C |
The verdict
Desk pick — NuvaHealthNuvaHealth takes this head-to-head with the higher Desk Score, 69/100 (C) against 68/100 (C) for Kin Meds. Kin Meds still holds its ground where its strengths line up with yours.
Choose Kin Meds if…
Readers who want compounded and brand-name GLP-1 plus a longevity stack on one platform.
$149/mo (brand Wegovy) sema · $149/mo (brand Zepbound) tirz · Coverage not published
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Choose NuvaHealth if…
Readers who want low first-month compounded GLP-1 pricing with 24/7 support.
$139/mo (first-month rate, compounded) sema · $229/mo (first-month rate, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Kin Meds · NuvaHealth.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Kin Meds vs CoreAge Rx
- NuvaHealth vs Vaylen
- Kin Meds vs Strut Health
- NuvaHealth vs Ondra Health
- Kin Meds vs Invigor Medical
- NuvaHealth vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.